The updated and most recent evidence of the occurrence and co-occurrence of mycotoxins.
FDA approves Iovance’s cell therapy for melanoma, the first treatment based on tumor-infiltrating lymphocytes
An experimental approach to treating cancer more than 40 years in the making finally has a long-sought and repeatedly delayed green light from the FDA.